GENETIC ETIOLOGY AND CLINICAL FEATURES OF ACHROMATOPSIA IN JAPAN

Retina. 2024 Oct 1;44(10):1836-1844. doi: 10.1097/IAE.0000000000004170.

Abstract

Purpose: To ascertain the characteristics of achromatopsia (ACHM) in Japan by analyzing the genetic and phenotypic features of patients with ACHM.

Methods: The medical records of 52 patients from 47 Japanese families who were clinically diagnosed with ACHM were reviewed in this retrospective observational study.

Results: Thirty-six causative variants of ACHM were identified in 26 families via whole-exome sequencing: PDE6C (12 families), CNGA3 (10 families), CNGB3 (two families), and GNAT2 (two families). However, none of the 6 causative variants that are known to cause ACHM, or the 275 other genes listed in RetNet, were observed in 19 families. A significant trend toward older age and worsening of ellipsoid zone disruption on optical coherence tomography images was observed (P < 0.01). Progressive ellipsoid zone disruptions were observed in 13 eyes of seven patients during the follow-up visits. These patients harbored one or more variants in PDE6C.

Conclusion: The ACHM phenotype observed in this study was similar to those observed in previous reports; however, the causative gene variants differed from those in Europe. The low identification ratio of causative genes in whole-exome sequencing suggests the presence of unique hotspots in Japanese patients with ACHM that were not detectable via ordinal whole-exome sequencing.

Publication types

  • Observational Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Child
  • Child, Preschool
  • Color Vision Defects* / diagnosis
  • Color Vision Defects* / genetics
  • Cyclic Nucleotide Phosphodiesterases, Type 6 / genetics
  • Cyclic Nucleotide-Gated Cation Channels / genetics
  • DNA Mutational Analysis
  • Electroretinography
  • Exome Sequencing*
  • Eye Proteins / genetics
  • Female
  • Humans
  • Japan / epidemiology
  • Male
  • Middle Aged
  • Mutation
  • Pedigree
  • Phenotype
  • Retrospective Studies
  • Tomography, Optical Coherence*
  • Visual Acuity
  • Young Adult

Substances

  • Cyclic Nucleotide Phosphodiesterases, Type 6
  • PDE6C protein, human
  • Eye Proteins
  • Cyclic Nucleotide-Gated Cation Channels